News & Updates

A lung nodule surveillance programme at Queen Mary Hospital (QMH) facilitates diagnosis of early-stage lung cancer. Data from the programme’s first year of implementation showed a higher proportion of early-stage lung cancer diagnoses compared with the Hong Kong Cancer Registry’s (HKCR) annual report.

Sotatercept, a first-in-class ac­tivin signalling inhibitor for pul­monary arterial hypertension (PAH), is approved in Hong Kong in August 2025, following regulatory ap­provals in Macau, the US, and the EU in February 2025. 

Once-daily, single-inhaler triple therapy with fluticasone fu­roate/umeclidinium/vilanter­ol (FF/UMEC/VI) outperforms twice-daily, single-inhaler triple therapy with budesonide/glycopyrrolate/for­moterol fumarate (BUD/GLY/ FORM) in the treatment of chron­ic obstructive pulmonary disease (COPD), two recent real-world comparative effectiveness studies have found. 

In a crossover trial evaluating the effect of two intermittent fasting (IF) regimens on long COVID (LC) symptoms, a daily 16-h fast with water-only fast and a no-sugar diet fared better than a daily 14-h time-restricted eating (TRE) regimen for mitigating long COVID symptoms.